StopDownOpen the app

Funding · Healthcare & Life Sciences

X STEP gets ₹1 crore on Shark Tank India

By ·

xStep logo
Date
Company
xStep
What it does
Spinal cord pacemaker for paralysis
Kind
Funding
Amount
₹1 crore
Sector
Healthcare & Life Sciences

What they do

X STEP develops a spinal cord pacemaker to help paralysis patients regain movement

What happened

Founder Parag Gad secured ₹1 crore from three sharks for 10% equity on Shark Tank India Season Five

Why it matters

The company plans to expand neuromodulation into diabetes and cardiovascular health

The details

  • X STEP founder Parag Gad appeared on Shark Tank India Season Five.
  • He asked for ₹1 crore for 1% equity in his company.
  • Three sharks — Namita Thapar, Vineeta Singh, and Kunal Bahl — together invested ₹1 crore for 10% equity.
  • X STEP is a medical innovation company at the intersection of neuroscience, engineering, and healthcare.
  • It develops a spinal cord pacemaker (neuromodulation) for paralysis patients to regain movement.
  • The technology stimulates specific spinal circuits, leveraging spinal memory.
  • The company's work is based on decades of research, including work by Dr. Edgerton.

The bigger picture

  • X STEP is described as 'born in CA, but built in Ka' — strong roots in California, with India central to its vision for scale and talent.
  • Parag Gad noted that deep tech healthcare innovation requires patience, credibility, regulatory approvals, and patient safety over speed.
  • Intellectual property is seen as foundational for deep tech — it signals seriousness and attracts global talent and investors.

About the business

  • X STEP is a medical innovation company at the intersection of neuroscience, engineering, and healthcare.
  • It develops a spinal cord pacemaker (neuromodulation) for paralysis patients to regain movement.
  • The technology stimulates specific spinal circuits, leveraging spinal memory.
  • Its revenue model is hybrid: device sales, structured therapy programs, and hospital partnerships.
  • The company is exploring neuromodulation applications for autonomic and metabolic functions: diabetes, cardiovascular health, and blood pressure.

What happens next

  • X STEP is exploring neuromodulation applications for autonomic and metabolic functions: diabetes, cardiovascular health, and blood pressure.

The deal

Type
equity

Investors

Founders

  • Parag Gad, founder

Read it as a card in the app

More on xStep

Everything on xStep →

Same day

All startup news on 24 January 2026 →